New Study Highlights Results of Diversey's Oxivir Tb Against MDROs
A recent study by William Rutala, PhD, MPH, published in the November 2012 issue of Infection Control and Hospital Epidemiology, showed that healthcare disinfectants containing improved hydrogen peroxide had greater efficacy than standard hydrogen peroxide or quaternary ammonium chloride (quat) disinfectants against community acquired methicillin-resistant Staphylococcus aureus (CA-MRSA), vancomycin-resistant Enterococcus (VRE) and multidrug-resistant (MDR) Acinetobacter baumannii. Diverseys Oxivir® Tb, based on patented AHP technology , is one of the improved hydrogen peroxide products referenced in the study. The Oxivir Tb product is further differentiated in the market by having the best safety profile possible for a disinfectant.Â
Numerous published studies have shown that environmental contamination plays a role in the transmission of healthcare-associated pathogens including MRSA, VRE, and MDR A. baumannii, says Carolyn Cooke, vice president of the healthcare sector at Diversey, now part of Sealed Air. This research demonstrates that Oxivir Tb, which has an excellent safety and environmental profile, offered exceptional efficacy at 30 seconds and 1-minute contact times against key pathogens commonly found in the healthcare environment.
AHP-based products, such as Oxivir Tb, are the only improved hydrogen peroxide disinfectants currently on the market that provide this combination of efficacy and safety. In all six EPA toxicity studies, Oxivir Tb falls into the category with lowest level of hazard, creating a safer environment for staff and patients.
Diverseys Oxivir line of products were introduced in 2006 to provide an alternative to traditional disinfectants by delivering fast acting, broad spectrum disinfection, with enhanced cleaning power that is friendly to staff, patients and surfaces. The active ingredient breaks down into oxygen and water within minutes after application.
Diversey is a business of Sealed Air Corp., a leader in food safety and security, facility hygiene and product protection.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
Clean Hospitals Corner With Alexandra Peters, PhD: The Issues Around Outsourcing
November 7th 2024Outsourcing environmental hygiene in health care facilities offers cost benefits but often compromises quality. Effective oversight, training, and standards are essential for ensuring patient safety.
Strengthening Defenses: Integrating Infection Control With Antimicrobial Stewardship
October 11th 2024Use this handout to explain the basics of why infection prevention and control and antimicrobial stewardship are essential and how the 2 fields must have a unified approach to patient and staff safety
